Apimeds Pharmaceuticals US, Inc. (APUS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$11.91M | -834.2% |
| 2024 | -$1.28M | -70.6% |
| 2023 | -$747.4K | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$11.91M | -834.2% |
| 2024 | -$1.28M | -70.6% |
| 2023 | -$747.4K | — |